Replication capacity and drug susceptibility of lopinavir-resistant HIV-2

被引：0
|
作者：
Mo, H.
Lu, X.
Masse, S.
Dekhtyar, T.
Lu, L.
Mondal, R.
Koev, G.
Ng, T.
Bernstein, B.
Gao, F.
Molla, A.
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [1] Selection of lopinavir-resistant HIV in CSF despite suppressed plasma HIV RNA during long-term RTV/lopinavir monotherapy leading to CNS disease
    Bierhoff, M.
    Boucher, C. A. B.
    Kuster, J.
    Ten Kate, R. W.
    [J]. ANTIVIRAL THERAPY, 2011, 16 : A121 - A121
  • [2] In vitro phenotypic susceptibility of HIV-2 clinical isolates to protease inhibitors:: Amprenavir, atazanavir, lopinavir, and tipranavir
    Descamps, D.
    Desbois, D.
    Damond, F.
    Collin, G.
    Matheron, S.
    Taieb, A.
    Peytavin, G.
    Bénard, A.
    Campa, P.
    Chêne, G.
    Brun-Vézinet, F.
    [J]. ANTIVIRAL THERAPY, 2006, 11 (05) : S103 - S103
  • [3] Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIV
    Flosi, William J.
    DeGoey, David A.
    Grampovnik, David J.
    Chen, Hui-ju
    Klein, Larry L.
    Dekhtyar, Tatyana
    Masse, Sherie
    Marsh, Kennan C.
    Mo, Hong Mei
    Kempf, Dale
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (19) : 6695 - 6712
  • [4] Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity
    Prado, JG
    Wrin, T
    Beauchaine, J
    Ruiz, L
    Petropoulos, CJ
    Frost, SDW
    Clotet, B
    D'Aquila, RT
    Martinez-Picado, J
    [J]. AIDS, 2002, 16 (07) : 1009 - 1017
  • [5] HIV-2 Susceptibility to Entry Inhibitors
    Borrego, Pedro
    Taveira, Nuno
    [J]. AIDS REVIEWS, 2013, 15 (01) : 49 - 61
  • [6] Antiviral Activity of Lenacapavir Against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-Resistant HIV-2 Mutants
    Smith, Robert
    Raugi, Dana
    Nixon, Robert
    Seydi, Moussa
    Margot, Nicolas
    Callebaut, Christian
    Gottlieb, Geoffrey
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (05): : 1290 - 1294
  • [7] In vitro analysis of replicative capacity and phenotypic susceptibility of integrase mutant HIV-2 viruses
    Le Hingrat, Q.
    Collin, G.
    Damond, F.
    Peytavin, G.
    Lebourgeois, S.
    Ghosn, J.
    Bachelard, A.
    Ferre, V.
    Matheron, S.
    Descamps, D.
    Charpentier, C.
    [J]. HIV MEDICINE, 2019, 20 : 173 - 173
  • [8] Antiretroviral drug-resistant HIV-2 infection - a new therapeutic dilemma
    Maniar, Janak K.
    Damond, Florence
    Kamath, Ratnakar R.
    Mandalia, Sundhiya
    Surjushe, Amar
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (11) : 781 - 782
  • [9] In vitro replication capacity of HIV-2 variants from long-term aviremic individuals
    Blaak, Hetty
    van der Ende, Marchina E.
    Boers, Patrick H. M.
    Schuitemaker, Hanneke
    Osterhaus, Albert D. M. E.
    [J]. VIROLOGY, 2006, 353 (01) : 144 - 154
  • [10] Inhibitory Effects of HIV-2 Vpx on Replication of HIV-1
    Mahdi, Mohamed
    Szojka, Zsofia
    Motyan, Janos Andras
    Tozser, Jozsef
    [J]. JOURNAL OF VIROLOGY, 2018, 92 (14)
12345